Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

TRDATRDA
Showing 8 of 19 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ENTRADA THERAPEUTICS INC

NORTHERN TRUST CORP holds 309,942 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $2.3M as of 2026-Q2. The position was increased (+31.9% shares). TRDA represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$2.3M

Current Shares

309,942

Total Value Change

-$1.7M

Total Shares Change

+62,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
309,942
+31.9%
$2.3M0.0%$7.36
33
2026-Q1
Increased
234,992
+3.8%
$3M0.0%$11.85
27
2025-Q4
Decreased
226,301
-10.8%
$2.3M0.0%$10.09
0
2025-Q3
Decreased
253,607
-15.6%
$1.5M0.0%$5.84
0
2025-Q2
Decreased
300,321
-3.2%
$2M0.0%$6.91
0
2025-Q1
Decreased
310,187
-2.5%
$2.8M0.0%$9.56
0
2024-Q4
Increased
318,177
+28.5%
$5.5M0.0%$17.37
34
2024-Q3
Increased
247,680
+30.1%
$4M0.0%$16.45
34

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used